Navigation Links
BioMS Medical Provides Update On Pipeline Products
Date:5/9/2008

ship with Eli Lilly and Company and to potentially expand our product pipeline with therapies in clinical stages or therapeutic areas that are more in keeping with our strategic focus," said Kevin Giese, President and CEO of BioMS Medical. "In addition we are very pleased with the HYC750 transaction in that it allows Orcrist to successfully capitalize on our earlier development work, while permitting us to retain access to some of the potential value it may hold."

About Orcrist Bio. Inc.

-----------------------

Orcrist Bio Inc. (http://www.orcristbio.com) is a biotechnology company dedicated to developing and commercializing promising therapeutics for areas in which a clear market opportunity exists. Orcrist's lead program revolves around HYC750, a novel stem cell mobilizer compound that promotes the egress of stem cells and other blood cells from the bone marrow into the blood, from which they can be harvested and applied toward treating chemotherapy-related white blood cell depletion. Orcrist is actively looking to add to its pipeline exploring the innate properties of HYC750 and its effects on stem cells, as well as through in-licensing opportunities of other products with clear market potential. Orcrist is located in Calgary, Alberta. The company is financed by its founders and by private investors.

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioMS Medical announces conference call and web cast for Annual General Meeting
2. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
3. BioMS Medical to present at EQUITIES Conference
4. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
5. BioMS Medical to present at BioCentury Conference
6. BioMS Medical Announces 2007 Year End Results
7. BioMS Medical to present at BIO CEO & Investor Conference
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
11. BioMS Medical announces third quarter 2007 results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...Calif., May 12 /- Alexza,Ph...y financial results for,its fiscal quarter ended M...y,s progress with its product candidates. The net ...d in accordance with accounting principles,general... million, compared,to a net loss of $10.9 million ...
(Date:5/12/2008)....J., May 12 /- MedQuist Inc...iption Service Organization,(MTSO) in the world, o...eport with the U.S. Securities and Exchange Commis...ue for the first quarter of 2008 was $83.7M compar...ecrease in revenue of $5.4M or 6% from,the prior y...
(Date:5/12/2008)...., May 12 /- TorreyPines,Th...that the company will,conduct a conference call an...a.m., Eastern Time (ET), in conjunction with the r...ter ended March 31, 2008. TorreyPines,anticipates ... Tuesday, May,13, 2008., To participate in this c...
(Date:5/12/2008)...if., May 12 /- Nektar,Thera...s proprietary,PEGylation technology is used in the...tide-based erythropoiesis-stimulating agent that i...velopment Center, Inc. and,Affymax. Data were pres...Congress in Stockholm, Sweden, which showed that H...
Breaking Biology Technology:Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 2Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 3Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 4Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 5Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 6Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 7Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 8Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 9Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 10MedQuist Reports First Quarter 2008 Results 2MedQuist Reports First Quarter 2008 Results 3MedQuist Reports First Quarter 2008 Results 4MedQuist Reports First Quarter 2008 Results 5MedQuist Reports First Quarter 2008 Results 6MedQuist Reports First Quarter 2008 Results 7MedQuist Reports First Quarter 2008 Results 8MedQuist Reports First Quarter 2008 Results 9TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast 2Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 2Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 3
...mon sense in project management isnt always so com...th-project scheduling, most projects are still lat...ed. Whats the problem? What should we do? After th... enough time to complete it; that the estimates fo...en you research and analyze the facts, the conclus...
...e Sen. Ted Kanavas, R-Brookfield, called on the Le...o create an Enterprise Management System Developme...n technology dollars allocated to agencies by the ...on of the funds for enterprise information managem...e would not flow into this fund. , ,This fund is l...
... column I wrote last year, I alluded to the intern... business has become global. In fact, there are no...ng to a May 2004 article in BioPharm International...publicly traded companies around the world. , , T... The industry employed more than 188,000 people ar...
...w days before Forbes magazine released its annual ...author and futurist Joel Kotkin spoke in Madison a...s as places to live and work. His conclusion was s... work just about anywhere, and post-nomadic Americ...ies. , ,Out-migration is dropping and even reversi...
Other Biology Technology:Part 3 Project performance Get on the path to continuous improvement 2Part 3 Project performance Get on the path to continuous improvement 3In Globalizing Biotech, Midwest Must Differentiate From Pack 2In Globalizing Biotech, Midwest Must Differentiate From Pack 3In Globalizing Biotech, Midwest Must Differentiate From Pack 4Forbes rating is more than kudos for Madison its a reflection on Wisconsin and the Midwest 2Forbes rating is more than kudos for Madison its a reflection on Wisconsin and the Midwest 3
(Date:5/12/2008)...LEY, CA -- In the late 19th century the Czech scie...onic compounds) aided the solution of proteins in ... and precipitate, and others ranged in activity be...nk "salt-out" (destabilizing) ions versus "salt-in.... The resulting "Hofmeister series" governs the st...
(Date:5/12/2008)...elease is available in Spanish . , Arlington,...ebody, or at least some dogs, have to do it. , I...to detect animal feces by scent are helping resear... jaguar, tapir, giant anteater and maned wolf in a...h the largest concentration of threatened species ...
(Date:5/12/2008)...CLE #1 FOR IMMEDIATE RELEASE , Identifying abno...urnal of Proteome Research , Researchers in Mas...ge gaps in medical knowledge about the biochemical... with diabetic retinopathy (DR) a leading cause o...scheduled for the June 6 issue of ACS monthly Jour...
(Date:5/11/2008)... YORK Researchers at Columbia University Medical ...ities in microRNAs, a family of molecules that reg... to the behavioral and neuronal deficits associate...rders. , , In the May 11 issue of Nature Geneti...ry, and Joseph A. Gogos, M.D., Ph.D., associate pr...
Breaking Biology News(10 mins):New clues to how proteins dissolve and crystallize 2New clues to how proteins dissolve and crystallize 3New clues to how proteins dissolve and crystallize 4Can feces save the species? 2Can feces save the species? 3American Chemical Society’s Weekly PressPac -- May 7, 2008 2American Chemical Society’s Weekly PressPac -- May 7, 2008 3American Chemical Society’s Weekly PressPac -- May 7, 2008 4American Chemical Society’s Weekly PressPac -- May 7, 2008 5American Chemical Society’s Weekly PressPac -- May 7, 2008 6American Chemical Society’s Weekly PressPac -- May 7, 2008 7American Chemical Society’s Weekly PressPac -- May 7, 2008 8Scientists dig deeper into the genetics of schizophrenia by evaluating microRNAs 2Alexza Initiates First Phase 3 Clinical Trial for AZ 004 28Staccato 28R 29 Loxapine 29 3472 1Alexza Initiates First Phase 3 Clinical Trial for AZ 004 28Staccato 28R 29 Loxapine 29 3472 2Alexza Initiates First Phase 3 Clinical Trial for AZ 004 28Staccato 28R 29 Loxapine 29 3472 3Alexza Initiates First Phase 3 Clinical Trial for AZ 004 28Staccato 28R 29 Loxapine 29 3472 4Alexza Initiates First Phase 3 Clinical Trial for AZ 004 28Staccato 28R 29 Loxapine 29 3472 5MacuSight 28TM 29 Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age Related Macular Degeneration 1419 1MacuSight 28TM 29 Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age Related Macular Degeneration 1419 2MacuSight 28TM 29 Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age Related Macular Degeneration 1419 3MacuSight 28TM 29 Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age Related Macular Degeneration 1419 4Meddius Unveils the Worlds Fastest Integration Appliance for the Healthcare Industry 12559 1Meddius Unveils the Worlds Fastest Integration Appliance for the Healthcare Industry 12559 2Meddius Unveils the Worlds Fastest Integration Appliance for the Healthcare Industry 12559 3Antares Management Solutions Earns Top ISO Re Certification 12555 1Antares Management Solutions Earns Top ISO Re Certification 12555 2
...the olfactory system of adult mice appear to play ...eurons. The new olfactory neurons are especially ...g to respond to new odors. This level of flexibil...ld be induced to adapt to and integrate into other...place neurons lost to injury or disease. The repo...
...ohnson from the Virginia Bioinformatics Institute ...at represents an ancient detoxification system and...olism on earth. , The research appears in the Nov....stry, in the article "A New Type of Sulfite Reduct...the Methanoarchaeon Methanocaldococcus jannaschii"...
...ately sense light governs everything from seed ger...rns of growth and flowering. , Now, for the first ...ne of biology,s most important light detectors, a ... fungal, and bacterial kingdoms. By resolving the ...s phytochrome, scientists can now tease out the se...
...anisms of wake-sleep transitions and epileptic sei...ania School of Medicine have demonstrated that sta...s are directly involved in regulating communicatio...is that astrocytes modulate the level of a signali...be important in controlling wake-to-sleep transiti...
Other Biology News:Neurons generated in the adult brain learn to respond to novel stimuli 2Novel protein complex enables survival in hostile environment 2Novel protein complex enables survival in hostile environment 3Novel protein complex enables survival in hostile environment 4Novel protein complex enables survival in hostile environment 5Scientists map one of biology's critical light-sensing structures 2Scientists map one of biology's critical light-sensing structures 3Penn study finds direct role for glial cells in brain cross-talk 2
... x 10 This pH 9.9 solution is intended for heat-i...al staining procedures. It is for use on formalin-...n glass slides. For particular antigens, target re...It should be noted that also endogenous biotin is ...
...the functionality of the micro1401 but with a fast...vailable channels of waveform input and output. Th...le front-end gain. Can be expanded from the standa...rm outputs at 16 bit resolution. Typical applicati...
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase
Biology Products: